Territory Manager- Livestock (Genomics & Animal Health)
Andersen CorporationSalary not specified
Full Time
Junior (1 to 2 years)
Not SpecifiedCompensation
Entry Level & New Grad, Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries
Requirements
- Bachelor’s degree (B.A./B.S) in animal or life sciences field preferred
- Minimum of one year experience in a rodent laboratory
- Proficiency in animal handling, husbandry, and technical procedures for rodent models
- Experience maintaining detailed records in lab notebooks
Responsibilities
- Support in vivo experiments by providing high-quality animal care and technical support
- Monitor animal health and welfare and document animal health observations
- Work with animal husbandry staff and scientists to maintain accurate records of animal procedures and inventory
- Assist in animal diet preparation and formulation
- Perform technical procedures such as compound dosing (PO, IP, SC), blood collection (tail, cheek, cardiac), anesthesia and euthanasia, and necropsy / tissue collection
Skills
rodent husbandry
animal handling
compound dosing
blood collection
anesthesia
euthanasia
necropsy
tissue collection
survival surgeries
PCR
qPCR
gel electrophoresis
NewLimit
Medicines for healthspan extension via epigenetics
About NewLimit
NewLimit develops medicines aimed at extending human healthspan by reprogramming aging cells' epigenomes. This involves changing the chemical modifications on DNA and histone proteins to restore youthful functions in old cells, focusing initially on rejuvenating the immune system and liver. The company uses advanced technologies like single-cell genomics and machine learning to identify aging markers and create interventions that reverse these changes. Unlike competitors, NewLimit's approach is centered on epigenetic reprogramming, targeting age-related diseases with the goal of creating a new class of medicines that enhance health during aging. The company serves the healthcare market, working with pharmaceutical companies and healthcare providers, and aims to transform aging by developing effective treatments.
South San Francisco, CaliforniaHeadquarters
2022Year Founded
$38.9MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Parental Leave
Unlimited Paid Time Off
Risks
Rapid biotech advancements could render NewLimit's technologies obsolete without continuous innovation.
Ethical concerns and regulatory scrutiny may delay product approvals.
Competition from similar biotech firms could impact NewLimit's market share.
Differentiation
NewLimit focuses on epigenetic reprogramming to extend human healthspan.
The company uses single-cell genomics and machine learning for drug discovery.
NewLimit targets age-related diseases with unmet needs, like immune system and liver rejuvenation.
Upsides
Increased interest in epigenetic reprogramming boosts NewLimit's market potential.
Machine learning aids in identifying novel drug candidates for age-related diseases.
FDA's favorable stance on aging therapies accelerates NewLimit's market entry.
Related Jobs
RemoteRemoteResearch Engineer
Chainlink LabsSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteDiagnostics Technical Specialist
ZoetisSalary not specified
RemoteBusiness Law Instructor
CampusSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)